Global Programme to Eliminate Lymphatic Filariasis ... - libdoc.who.int

C H A P T E R 5THE GLOBAL INITIATIVE — THE WAY FORWARD119By the end of 2003, 70.2 million people were reported increase over the achievement of 60 million individualsto have ingested a two-drug combination of DEC plus covered in 2002, it is still only 6% of the global at-riskalbendazole or ivermectin plus albendazole,covering a population. For an overview of the number of peopletotal population of 98 million in the IUs where MDA was covered by MDA since 1999, see Figure 5.2implemented (see Figure 5.1). Though this was a 36%Figure 5.1 Global population covered by MDA, 2000–2003100Pop. targeted according to the 1999 Strategic PlanPop. targeted in IUs80Pop. covered in IUsAnnual Report on Lymphatic Filariasis 2003Population in millions604020020002001Figure 5.2 Number of people covered by MDA since 1999403026 M200234 M2003Chapter 5 The Global Initiative – The Way ForwardPopulation in millions201011 M3 M0.09 M05th MDA4th MDA3rd MDA2nd MDA1st MDAMoreover, most of the populations covered belong to thelower-middle and middle income group countries, whilethe lowest proportion covered is in the least developedcountries where the highest proportion of the populationis at risk of LF; these are also the most difficult populationsto reach (see Table 5.1).